期刊文献+

Survivin和CK19在肝细胞癌中的表达及意义

THE EXPRESSION OF SURVIVIN AND CK19 AND THEIR CLINICAL SIGNIFICANCE IN HEPATOCELLULAR CARCINOMA
下载PDF
导出
摘要 目的研究survivin和CK19在肝细胞癌(Hepatocellular carcinoma HCC)中的表达及临床病理意义。方法采用组织芯片技术及免疫组化SP法,研究296例HCC和81例癌旁组织中survivin和CK19的表达,并探讨其与临床病理特征及预后的关系。结果 1survivin和CK19在HCC中表达的阳性率分别为72.3%(214/296)和14.5%(43/296),均高于癌旁组织的9.9%(8/81)和0(0/81),差异均有统计学意义(P均<0.05)。2Survivin在HCC中的表达与组织学分级、临床分期、术后无瘤生存时间、肿物直径、淋巴结转移及肝被膜浸润相关,差异具有统计学意义(P均<0.05),与其他指标无关(P均>0.05);CH19在HCC中的表达与肝硬化、组织学分级、临床分期和淋巴结转移相关,差异具有统计学意义(P均<0.05),与其他指标无关(P均>0.0)。3Kaplan-Meier生存分析显示,survivin和CK19在HCC中表达阳性的患者无论其术后无瘤生存时间还是其总生存时间均短于阴性表达患者,差异均具有统计学意义(P均<0.05)。4Pearson相关分析示,survivin和CK19在HCC中的阳性表达呈正相关(r=0.146,P=0.012)。结论 HCC中survivin和CK19的阳性表达与多种临床病理指标相关,两者均可作为HCC患者预后不良的判断因子。 Objective To study the expression of survivin and CK19 protein and their clinicopathologic significance in hepatocellular carcinoma (HCC) .Meth‐ods The expression of suevivin and CK19 were deter‐mined by tissue microarray and immunohistochemistry 〈br〉 in 296 cases of HCC and 81 cases of non‐cancerous tissue .T he relationships betw een their expression and the clinicopathologic parametersand ,the survival time of patients w ere analyzed .Results T he possive rates of survivin and CK19 in HCC were 72 .3% and 14 .5% ,which were higher than those in non‐cancerous tis‐sue( P 〈0 .05) .The expression of survivin in HCC was closely correlated to the histological grade ,TNM clicinal stage ,survival time ,lymph node mestastasis ,tumor diameter and liver capsule invasion( P 〈0 . 05) ,but not to the rest of parameters .The xpression of CK19 in HCC was closely correlated to the liver cirrhosis ,the histological grade ,TNM clicinal stage and lymph node mestastasis( P 〈0 .05) ,but not to the rest of parameters .The positive expression of survivin and CK19 were significantly related to short‐term survival by Kaplan‐Meier analysis ( P〈0 .05) .The two markers were positively interrelated ( r =0 . 146 ,P =0 .012) .Conclusion The positice expression of survivin and CK19 closely correlates with multiple clinicopathologic parameters ,w hich may indicate the poor prognosis of HCC .
出处 《山东医学高等专科学校学报》 2015年第4期284-288,F0002,共6页 Journal of Shandong Medical College
关键词 肝肿瘤 CK19 组织芯片 免疫组化 survivin Liver neoplasm Survivin Tissue microarray Immunohistochemistry
  • 相关文献

参考文献10

  • 1汤钊猷.从肝癌看癌症临床研究[J].肿瘤,2009,29(1):1-4. 被引量:42
  • 2郭晓东,杨美,余灵祥,郭超楠,熊璐.Caspase-9和Survivin在肝细胞癌患者癌组织中的表达[J].肝脏,2014,19(9):661-663. 被引量:5
  • 3丁玉梅,马丽丽,窦洪涛,王新美,丁宁,于小辉.人宫颈癌组织中survivin的表达与临床分析[J].中国医学创新,2014,11(6):36-39. 被引量:5
  • 4王海燕,黄爱民,高美钦,高凌云.Survivin、CD105在乳腺癌中的表达及其意义[J].河北医科大学学报,2011,32(8):965-968. 被引量:3
  • 5Li F, ALTIERI DC. The cancer antiapoptosis mouse survivin gene characterization of locus and transcrip- tional requireiment of basal and cell cycle-dependent expnessionEJ-. Cancer , 1999,59(13) : 3143-3151.
  • 6MIRZA A, MCGUIRK M, HOCKENBERRY TN, et aL Human Survivinis negatively regulated by wild-type P53 and participates in P53-dependent apoptotic path- way [J],Oneogene, 2002,21(17)-2613-2633.
  • 7Klamura H, Torigoe T, Honma I, et al. Expression and antigenicity of survivin an inhibitor of apoptosis family member, in bladder cancer implication for spe- cific immunotherapy [J]. Urology, 2006, 67(9):955- 959.
  • 8王为东,李玉军.肝细胞肝癌中端粒酶、p53和CK19的表达及意义[J].临床与实验病理学杂志,2012,28(8):862-866. 被引量:7
  • 9Qian YB, Zhang JB, Wu WZ, et al. P48 is a predic- tive marker for outcome of postperative inter emn-al- pha treatment in patients with hepatitis B virus infec- tion-related hepatocellular carcinoma [ J ]. Cancer, 2006,107(7) : 1562-1569.
  • 10Ding SJ, Li Y, Tan YX, et al. From proteomic anal- ysis to clinical significance: overexpression of cytoker- atin 19 correlates with hepatocellular carcinoma metas- tasis [J]. Mol Cell Proteomics, 2004,3(1) :73-81.

二级参考文献68

  • 1尹如铁,彭芝兰,杨开选,康德英.Survivin蛋白在卵巢癌中的表达和意义[J].四川大学学报(医学版),2006,37(2):215-217. 被引量:10
  • 2Deng-Fu Yao,Wei Wu,Min Yao,Li-Wei Qiu,Xin-Hua Wu,Xiao-Qin Su,Li Zou,Deng-Bing Yao,Xian-Yong Meng.Dynamic alteration of telomerase expression and its diagnostic significance in liver or peripheral blood for hepatocellular carcinoma[J].World Journal of Gastroenterology,2006,12(31):4966-4972. 被引量:9
  • 3喻宏,钟仁华,黄振林.P53、AR、ER在原发性肝癌、癌旁组织中的表达及意义[J].国际医药卫生导报,2006,12(24):12-14. 被引量:8
  • 4官泳松,刘源,贺庆.血清P53抗体与原发性肝癌临床特征的关系[J].世界华人消化杂志,2007,15(3):246-253. 被引量:10
  • 5THAKER PH, HAN LY, KAMAT AA, et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma[J]. Nat Med, 2006, 12(8) :939-944.
  • 6NIETERS A, YUAN JM, SUN CL, et al. Effect of cytokine genotypes on the hepatitis B virus-hepatocellular carcinoma association [J]. Cancer, 2005, 103(4):740-748.
  • 7BUDHU A, FORGUES M, YE Q H, et al. Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment[J]. Cancer Cell, 2006, 10(2) :99-111.
  • 8LIN M C, WU C C, CHENG S B,et al. The influence of high serum testosterone levels on the long-term prognosis in male patients undergoing hepatectomy for early stage hepatocellular carcinoma without vassular invasion [ J ]. World J Surg, 2007,31 ( 7 ) : 1469- 1473.
  • 9CUCCHETTI A, SINISCALCHI A, ERCOLANI G, et al. Modification of acid-base balance in cirrhotic patients undergoing liver resection for hepatocellular carcinoma[ J]. Ann Surg, 2007, 245 (6) :902-908.
  • 10MURATA K, MORIYAMA M. Isoleucine, an essential amino acid, prevents liver metastases of colon cancer by antiangiogenesis [ J ].Cancer Res, 2007, 67 ( 7 ) : 3263-3268.

共引文献54

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部